Company Filing History:
Years Active: 2022
Title: Tinglan Tina Albershardt: Innovator in Cancer Treatment
Introduction
Tinglan Tina Albershardt is a notable inventor based in Olympia, WA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Tina holds one patent titled "Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof." This patent application focuses on the treatment of cancer, specifically utilizing a pseudotyped lentivirus that expresses IL-12 for therapeutic purposes.
Career Highlights
Tina is currently associated with Immune Design Corp., where she continues to advance her research in immunotherapy. Her work is pivotal in developing new strategies for cancer treatment, showcasing her dedication to improving patient outcomes.
Collaborations
Tina collaborates with esteemed colleagues such as Jan Henrik Ter Meulen and Peter Lars Aksel Berglund, contributing to a dynamic research environment that fosters innovation.
Conclusion
Tinglan Tina Albershardt is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. Her contributions are vital to the ongoing fight against cancer, and her patent reflects her commitment to advancing therapeutic options.